ADARx Pharmaceuticals
CA - San DiegoPharmaceutical
Focus: ADARx Pharmaceuticals is a San Diego-based RNA therapeutics company focused on neurology and gene therapy. The company operates as a pre-revenue clinical-stage biotech with a modest pipeline in early-to-mid development.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Open Jobs
6
Should You Work at ADARx Pharmaceuticals?
AI assessmentADARx is a high-risk, high-impact early-stage bet best suited for mission-driven RNA scientists willing to weather funding uncertainty for meaningful platform ownership.
Why Work Here
- Early-stage RNA platform play with two distinct therapeutic programs (ADX-324 in Phase 3, ADX-850 in Phase 1) offering exposure to cutting-edge modality across neurology and systemic indications
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ADX-850
HypertensionClinical Trials (1)
NCT06205628Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension
Phase 1Help build intelligence for ADARx Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.